Company profilePharmaceutical#309 of 1,318 in Pakistan✓ No DRAP alerts

RAAZEE THERAPUTICS (PVT) LTD.

Pharmaceutical company · 56 brands · 95 molecules

Ranked #18 of 62 companies in Drugs For Obstructive Airway Diseases, Systemic

56 registered products 18 pharmaceutical brands 95 distinct molecules 0 DRAP alerts

Company overview

56
registered products
18
pharmaceutical brands
95
distinct molecules
12
therapeutic classes
0
DRAP alerts

RAAZEE THERAPUTICS (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 56 product registrations across 95 distinct molecules. Its portfolio is concentrated in Drugs For Obstructive Airway Diseases, Systemic and Ace Inhibitor. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Ibuprofen2 brands
Acefylline2 brands
Ranitidine2 brands
Nutritional Supplement / Multivitamin1 brand

Therapeutic classes

Drugs For Obstructive Airway Diseases, Systemic · 2Ace Inhibitor · 2Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives · 1Lipid Modifying Agents · 1Anti-Infectives · 1Blood Glucose Lowering Drugs, Excluding Insulin · 1Antidepressants · 1Antianemic, Iron Preparations · 1Angiotensin-Ii Antagonists, Combinations · 1Psychostimulants, Nootropic & Neurotonic · 1Fever/Flu/Cough · 1Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 1

Conditions treated

General Infections · 1Cold/Dry Cough · 1Pain Killers · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official32 products · Rs 48.54 – Rs 1,798.69
Servaid4 products · Rs 43.4 – Rs 199.02
Median across source: Rs 331.61

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for RAAZEE

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.